-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Arcutis Biotherapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q1 2023 to Q2 2025.
- Arcutis Biotherapeutics, Inc. Costs and Expenses for the quarter ending June 30, 2025 was $96.1M, a 18.8% increase year-over-year.
- Arcutis Biotherapeutics, Inc. Costs and Expenses for the twelve months ending June 30, 2025 was $349M, a 12% increase year-over-year.
- Arcutis Biotherapeutics, Inc. annual Costs and Expenses for 2024 was $325M, a 8.06% increase from 2023.
- Arcutis Biotherapeutics, Inc. annual Costs and Expenses for 2023 was $301M, a 1.51% decline from 2022.
- Arcutis Biotherapeutics, Inc. annual Costs and Expenses for 2022 was $305M, a 47.8% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)